GRTP1
Growth hormone-regulated TBC protein 1
Also known as: FLJ22474, GRTP1_HUMAN, TBC1D6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TC63
- Gene
- GRTP1
- Ensembl
- ENSG00000139835
- Chromosome
- 13
- Canonical length
- 336 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable GTPase activator activity. Predicted to be active in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
336 residues, UniProt reviewed canonical sequence.
>Q5TC63|GRTP1
1 MQPAERSRVP RIDPYGFERP EDFDDAAYEK FFSSYLVTLT RRAIKWSRLL QGGGVPRSRT
61 VKRYVRKGVP LEHRARVWMV LSGAQAQMDQ NPGYYHQLLQ GERNPRLEDA IRTDLNRTFP
121 DNVKFRKTTD PCLQRTLYNV LLAYGHHNQG VGYCQGMNFI AGYLILITNN EEESFWLLDA
181 LVGRILPDYY SPAMLGLKTD QEVLGELVRA KLPAVGALME RLGVLWTLLV SRWFICLFVD
241 ILPVETVLRI WDCLFNEGSK IIFRVALTLI KQHQELILEA TSVPDICDKF KQITKGSFVM
301 ECHTFMQKIF SEPGSLSMAT VAKLRESCRA RLLAQGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRTP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 78 nTPM
Expression across tissuesHPA
Tissue
- liver: 78 nTPM
- duodenum: 43 nTPM
- small intestine: 37 nTPM
- skin: 24 nTPM
- colon: 23 nTPM
- esophagus: 20 nTPM
Single-cell type
- enterocytes: 136 nCPM
- cone photoreceptor cells: 130 nCPM
- rod photoreceptor cells: 120 nCPM
- colonocytes: 117 nCPM
- paneth cells: 101 nCPM
- prostatic hillock cells: 86 nCPM
Immune cell
- neutrophil: 2.1 nTPM
- basophil: 0.6 nTPM
- total PBMC: 0.6 nTPM
- naive CD4 T-cell: 0.5 nTPM
- non-classical monocyte: 0.5 nTPM
- classical monocyte: 0.4 nTPM
Brain region
- choroid plexus: 15 nTPM
- cerebral cortex: 14 nTPM
- cerebellum: 9.8 nTPM
- white matter: 8.8 nTPM
- medulla oblongata: 8.7 nTPM
- spinal cord: 8.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.44
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRTP1 as an antibody target. Whether an autoantibody or antibody against GRTP1 could matter depends on whether native GRTP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRTP1 is annotated at the cell surface, where native GRTP1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRTP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...